INTRODUCTION
The United States Transuranium and Uranium Registries (USTUR) maintains an extensive and growing database of health physics information and measured actinide content of tissues for former workers who were known to have had intakes of actinide elements during their employment in the nuclear industry. These registrants had volunteered to donate tissues after their death for radiochemical analyses and biokinetic modelling studies. Case 0262, the subject of this study, is of particular interest since his intakes were well documented, and they occurred as two discrete (acute) inhalation events, with a further intake via a cutaneous puncture wound. Case 0262 is a whole body donation, for whom USTUR has analysed radiochemically the contents of Am data, and biokinetic modelling of 241 Am in-growth in tissues from 241 Pu decay of the Pu material taken into the body will be reported elsewhere. This paper is concerned with modelling the systemic uptakes of Pu from both inhalations and the wound, and the subsequent long-term tissue retention of Pu.
THE DONOR
This gentleman worked as an engineer at the Hanford site, from 1951 to 82. He died in 1990, at the age of 71, from hepatocellular carcinoma with metastases to the diaphragm, lungs and liver. Incidental autopsy findings included degenerative arthritis of hip and shoulder joints, and diffuse degenerative changes of the lumbar spine (indicative of osteoporosis). At autopsy, the skin was taken from both hands in order to examine both for residual actinide activity, together with the axillary lymph node associated with the left hand. The skin wound occurred on the left thumb.
Health physics/incident data
In 1956, this worker had two suspected intakes of nominally 'fresh' weapons grade Pu. In the first incident, with no respiratory protection worn, a substantial airborne Pu concentration was detected. In the second incident, 2 weeks later, both hands were heavily contaminated (exceeding 10 000 dpm alpha activity). Urine samples taken promptly after both incidents had measurable Pu alpha activity. However, subsequent urine samples had no measurable Pu alpha activity (,0.025 dpm per 24 h sample). The Pu urinalysis method (1) was (1) separation of the 241 Am contaminant by lanthanum fluoride precipitation and thenoyl trifluoroacetone extraction of plutonium, (2) electrodeposition of the Pu isotopes on a stainless steel disk and (3) counting of total alpha activity using nuclear track emulsion autoradiography (a-track counting).
The third intake (Pu wound to left thumb) occurred $500 d later, when a broken drill bit punctured the worker's left glove while he was working in a glove box. The initial external count rate at the wound site, measured by a-probe, was about 500 cpm. There was no general airborne release, but the glove involved in the incident was highly contaminated with $40 000 dpm (667 Bq) of alpha activity.
Wound and medical management
Medical findings were a 1 4 -in. laceration ( 1 8 -in. deep) on the terminal phalanges of the left thumb with little or no bleeding. A suction cup was applied and $2 ml of fluid was obtained. There was apparently no alpha activity above the background in the fluid removed, but information about the detection method used is not available. The initial count rate from the wound site was reduced somewhat by washing the skin with a decontamination agent, but there was no mention in the dosimetry records of subsequent chelation therapy or surgical removal of tissue.
At $7 y after the wound intake, the registrant's employer estimated that his total lifetime systemic uptake of plutonium would be $2.3 nCi (84 Bq) of Pu (primarily Pu. This corresponded to $15% of the contemporary 'maximum permissible body burden' (2) . The estimated Pu uptake was derived from graphical analysis of the Pu-in-urine bioassay data, using the Langham (3) power function method to resolve the component of systemic uptake due to initially 'soluble' plutonium, i.e. that absorbed within days, and the Healy (4) method for the component from initially 'insoluble' or slowly absorbed plutonium. The relative amount of 241 Pu was estimated from an assumed isotopic ratio of the source material.
AUTOPSY TISSUE DATA

Skin and wound site
The skin of the left thumb (containing the wound site) was not analysed radiochemically. This has been preserved for a-particle autoradiography and histological study. The total 239þ240 Pu and 241 Am contents were measured by photon spectrometry using a low-energy planar Ge (LEGe) detector. The skin sample, $0.5-cm thick, was prepared by stretching it on a flat surface and counting successively with the inner and outer surface facing the LEGe detector, at distances of 1.5 and 4 in. The emission rate for 17 keV X-rays was approximately equal from the inner and outer surfaces of the skin, indicating a mid-depth location of the Pu source material. An appropriate correction was made for self-absorption in the overlying tissue. Table 1 gives a summary of the total 239þ240 Pu activity measured (by radiochemical analysis) in major organs and the left axillary lymph node (associated with the left thumb wound). The full radiochemical analysis results ( 238 Pu, 239þ240 Pu and 241 Am) measured in all sampled tissues (including individual bones) can be downloaded from http:// www.ustur.wsu.edu/Montpellier/index.html
Other tissues
DATA ANALYSIS AND RESULTS
The software package IMBA Expert TM USDOEEdition (5) was used first to derive the amounts and characteristics of the two initial intakes by (7) Reference Worker. The uptake and retention of Pu in the major body organs, and the excretion in urine and faeces, is represented by the ICRP Publication 67 (8) biokinetic model for Pu (IC67). The software does not distinguish between material retained at the wound site and that translocated (as particles) to an associated lymph node. Instead, all particulate activity that was initially deposited in the 'wound' is treated as material in one or more 'extra-systemic' compartments. These compartments are assumed to release Pu at a constant rate, by the process of dissolution and absorption of Pu into the blood. Thus, the total 'extrasystemic' retention of Pu at the wound site and/or any associated lymph nodes is represented by the sum of one or more exponentially cleared compartments.
Given the observed bioassay data and a specific set of assumptions about the characteristics of any intakes, the IMBA Expert TM software applies the 'maximum-likelihood method' to evaluate simultaneously the most likely amounts of each intake (9) . The maximum-likelihood method enables appropriate statistical weight to be applied to data values recorded as 'less than the limit of detection', as are present in both the early urinary excretion data for this case, and that beyond 14 y. The error distribution for the urine data was assumed to be lognormal, where the associated value of s g was determined empirically to reflect the observed 'scatter' in sequential data points.
The 'best-fit' values of absorption rates, and other model parameters were found by minimising the calculated value of the x 2 -sum, with the fitted parameter values constrained to predict exactly the measured lung, thoracic lymph node and whole body activity (Table 1 ). The whole body activity included the residual amounts of Pu measured at death in the skin wound and the associated axillary lymph node. These initial estimates from The IMBA Expert TM analysis are shown in Table 2 . The 'IMBA' estimates were used as initial values to carry out a more comprehensive analysis of the specific values of dominant rate constants in the IC67 Pu biokinetic model that are applicable for this individual donor, as described below.
The combined wound, axillary lymph node and systemic Pu model system, shown in Figure 1 was solved analytically in successive time-steps corresponding to the three intake events, all urine sampling intervals, and the time of death, using the 'rate matrix' method (10, 11) . The rate matrix was solved iteratively, using the 'grid-search' method (12) to find the combination of trial parameter values that minimises the calculated value of Sx 2 urine. This analysis was performed twice: (1) with all rate constants in the IC67 Pu biokinetic model set to ICRP's recommended values, and (2) also varying iteratively the systemic Pu model parameter values which minimise Sx 2 total , i.e. provide a simultaneous exact fit to the measured organ contents (Sx 2 organ ¼ 0). Figure 2 shows the corresponding best fits to the urine bioassay data so obtained.
Note that the ICRP-recommended Pu biokinetic model parameter values give almost as good a 'fit' to the urine data (Sx 2 urine ¼ 45.1) as the case-specific values 'optimised' to fit to the measured organ contents (Sx 2 urine ¼ 42.7). Table 3 shows the resulting 'best-fit' to the measured tissue contents obtainable with all ICRPrecommended parameter values in the Pu systemic model, together with modified parameter values in the HRTM (IC66). The optimisation of the critical parameter values in the IC67 systemic Pu model reduced all of the residual 'error' values shown in Table 3 to zero, i.e. predicted exactly the measured organ contents. Table 4 shows the modifications to ICRP's reference parameter values (multiplying factors) needed to match the organ contents measured in this individual whole body donor.
Derived characteristics of inhaled Pu material
The urinary excretion pattern shown in Figure 2 (inset) is not consistent with that predicted by the ICRP default parameters for insoluble Pu (type S). The following case-specific parameter values were found to predict both the measured total lung burden of 239þ240 Pu at death (3.64 Bq at 12 536 d after the first inhalation intake) and the measured thoracic lymph nodes (LNTH) burden of 1.05 Bq, while simultaneously minimising the value of Sx 2 urine and fitting exactly the measured 239þ240 Pu contents of major organs: Derived wound/axillary node intake and retention 
There was no visible scarring of the skin (wound site) containing this Pu material. The analysis carried out here (with the wound/ lymph node biokinetic model structure shown in Figure 1 ) assumes rapid initial partitioning of deposited particles (by lymphatic flow) between the wound site and the axillary node, where the partition fraction is assumed to be defined by the ratio of node: wound activity measured at autopsy. Thus, the timedependent absorption rates are assumed to be identical for particles retained at the wound site and those transferred to the axillary node. The actual rate of lymphatic transfer to the axillary node cannot be resolved from the urine bioassay and autopsy tissue data alone. The observed multi-phased wound/lymph node retention characteristics indicate that the Pu contamination in the glove box consisted predominantly of highly insoluble PuO 2 mixed with $14% of 'soluble' Pu.
Organ/tissue contents predicted as a function of time Figure 3 shows the temporal pattern of uptake by systemic organs predicted by the modified IC66/67 model parameters (Table 4) in this case, in comparison with the respective organ contents measured at autopsy. With the predominant, very slow uptake of Pu from the wound and axillary lymph node, the maximum amount of total 'systemic' activity occurred at the end of life (34 y after the first inhalation intake), i.e. the maximum 'body burden' is that directly measured at autopsy.
Thus, the maximum total systemic activity measured in this case is 52 Bq (1.4 nCi), where this includes the activity measured in the lungs and thoracic lymph nodes, but excludes that retained in the skin wound and axillary lymph node. Applying the IC67 Pu biokinetic model for the Reference Worker (and the ICRP Publication 60 tissue weighting factors) (13) , the effective dose (resulting from the 239þ240 Pu in these three intakes) is $35 mSv (3.5 rem).
CONCLUSIONS AND COMMENT
The fitted long-term absorption rate of 2 Â 10 25 d
21
for the Pu material inhaled in this case ( presumed to be PuO 2 ) is one-fifth of ICRP's recommended default value for type S (of 10 24 d
). In conjunction with this slower absorption rate, the fitted rate of particle transfer to the thoracic lymph nodes (AI3 ! LNTH pathway) is about half the ICRP default value of 2 Â 10 25 d 21 . The long (33 y) follow-up of this USTUR whole body donor has enabled the extremely slow absorption of PuO 2 from a skin puncture wound to be observed. In this case, only about one-quarter of the initially deposited 'insoluble' material was absorbed into the blood. Only relatively small changes to some of ICRP's recommended parameter values in the Pu biokinetic model were necessary to predict exactly the tissue contents of Pu measured at autopsy. However, these autopsy measurements showed greater than predicted retention in trabecular bone with relatively lower retention in cortical bone.
In the authors' opinion, this case demonstrates the remarkable skill, judgement and 'prescience' of the 1950s site pre-health physicists and medical practitioners, who, on the basis of limited contemporary knowledge and primitive computational tools, succeeded in predicting this gentleman's total systemic Pu content (measured three decades later) to within a factor of 2! DISCLAIMER Neither the US Government nor any agency thereof, nor any of their employees, makes any warranty, expressed or implied, or assumes any legal liability or responsibility for the accuracy, completeness or usefulness of any information, apparatus, product or process disclosed, or represents that its use would not infringe privately owned rights. Reference herein to any specific commercial product, process or service by trade name, trademark, manufacturer or otherwise does not necessarily constitute or imply its endorsement, recommendation or favouring by the US Government or any agency thereof. The views and opinions of authors expressed herein do not necessarily state or reflect those of the US Government or any agency thereof. 
